da sha ti ni pian zai zhong guo jian kang ren ti nei de yao dong xue
SU Hao-ming;ZHU Ting-ting;SONG Min;MA Xiao-juan;ZHANG Wei-wei;YANG Lin;WEN Ai-dong;HANG Tai-jun;Department of Pharmaceutical Analysis;China Pharmaceutical University;Jiangsu Chia-tai Tianqing Pharmaceutical Co.;Ltd.;R&D Center;Xijing Hospital Affiliated to the Fourth Military Medical University;
..............page:2060-2064
..............page:2071-2074
..............page:2048-2052
..............page:2065-2068
..............page:2081-2085
..............page:2046-2047
..............page:2033-2037
..............page:2038-2042
..............page:1998-2001
fei xiao xi bao fei ai ji yin jian ce de lin chuang yi yi
HAN Xiao-hong;ZHANG Ning-ning;SHI Yuan-kai;Department of Medical Oncology;Cancer Institute/Hospital;Chinese Academy of Medical Sciences & Peking Union Medical College;Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs;
..............page:2021-2026
..............page:1994-1997+2006
..............page:2069-2070+2074
..............page:2097-2102
..............page:2093-2096+2102
..............page:2090-2092
..............page:2002-2006
..............page:2027-2032
..............page:1990-1993
..............page:1979-1980
..............page:1981-1982
..............page:1983-1989+1993
..............page:2075-2080
..............page:2016-2020
..............page:2007-2011
..............page:2053-2059
..............page:2012-2015
..............page:2043-2045+2052
..............page:2086-2089